20–40 mcg — reported, not studied
20–40 mcg once a day, ideally after training, under the skin. Runs of four to six weeks with an equal break follow it. Published research on this analogue is limited to animals and cells. No study in a person has ever been registered.
| Water added | Concentration | Draw, low to high |
|---|---|---|
| 1 mL | 0.10 mg/mL | 20.0 to 40.0 units |
| 2 mL | 0.05 mg/mL | 40.0 to 80.0 units |
indirect evidenceDominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, Ruchała M. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol 2026 — tabulates self-reported online dosing patterns beside the clinical doses, stating the reported values must not be read as clinically validated, regulatory-approved or safe · retrieved 2026-08-12
